CM 4620Alternative Names: CM-4620
Latest Information Update: 23 Jan 2017
At a glance
- Originator CalciMedica
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Immunosuppressants; ORAI1 protein inhibitors; STIM1 protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Pancreatitis